Jubilant Considers Splitting Itself Into Two for Greater Focus

31 Jul 2019

• By Aidan Fry

Jubilant’s board is considering whether to create separate entities for its Pharmaceuticals and Life Science Ingredients business segments to give each greater focus.

Croissant — Jubilant is considering whether to divide its business in two, splitting off its Pharmaceuticals business • Source: Shutterstock

Jubilant Life Sciences’ board of directors has formed a committee to evaluate strategic options for restructuring its business to create “focused entities” for its Pharmaceuticals and Life Science Ingredients business segments.

The committee is pondering whether to “create separate and focused entities for Pharmaceuticals and Life Science Ingredients businesses to manage...